![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1494894
ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå ¿¹Ãø(-2030³â) : À¯Çüº°, ±¸¼º¿ä¼Òº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®Brain Computer Interface Market Forecasts to 2030 - Global Analysis By Type (Invasive, Non-Invasive, Partially Invasive and Other Types), Component, Technology, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀåÀº 2024³â 25¾ï ´Þ·¯ ±Ô¸ðÀ̸ç, ¿¹Ãø ±â°£ µ¿¾È 21.5%ÀÇ CAGR·Î 2030³â¿¡´Â 80¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI)´Â ³ú-±â°è ÀÎÅÍÆäÀ̽º(BMI)¶ó°íµµ ºÒ¸®¸ç, ±ÙÀ°À» ÅëÇÑ Á¦¾î ¾øÀÌ ³ú¿Í ÄÄÇ»ÅÍ ¶Ç´Â ÀÇÁ·°ú °°Àº ¿ÜºÎ ÀåÄ¡¿Í Á÷Á¢ Åë½ÅÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ½Ã½ºÅÛÀÔ´Ï´Ù. ±â´ÉÀû ÀÚ±â°ø¸í¿µ»ó¹ý(fMRI), ±ÙÀû¿Ü¼± ºÐ±¤¹ý(NIRS) µî ³úÀÇ È°µ¿À» ÇØ¼®ÇÏ´Â ´Ù¾çÇÑ ¹æ¹ýÀ» »ç¿ëÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Àå¾ÖÀÎ º¸Á¶ ±â¼ú Á¦¾î, Àΰ£ ´É·Â È®Àå, ³ú ±â´É ¹× ÀÎÁö ¿¬±¸ µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
WHOÀÇ º¸°í¼¿¡ µû¸£¸é 2030³â±îÁö ¾à 8,200¸¸ ¸íÀÌ Ä¡¸Å¿¡ °É¸± °ÍÀ̸ç, 2050³â¿¡´Â ÀÌ ¼ýÀÚ°¡ 1¾ï 5,200¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ̶ó°í ÇÕ´Ï´Ù. ÀÌ´Â ÇâÈÄ ¸î ³â µ¿¾È BCIÀÇ ÀáÀçÀû ¼ö¿ä¸¦ º¸¿©ÁÝ´Ï´Ù.
»îÀÇ ÁúÀû Çâ»ó °¡´É¼º
ÀÌ ½ÃÀåÀº »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ¾öû³ ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ³ú¿Í ¿ÜºÎ ±â±â¿ÍÀÇ ¿øÈ°ÇÑ »óÈ£ ÀÛ¿ëÀ» ÅëÇØ ÀÇ·á, Ä¿¹Â´ÏÄÉÀ̼Ç, Á¢±Ù¼º¿¡ Çõ¸íÀûÀÎ °¡´É¼ºÀ» °¡Á®´Ù ÁÙ ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀº Àå¾ÖÀÎÀÇ ÀÚÀ²¼ºÀ» Çâ»ó½Ã۰í, ÀǼö Á¶ÀÛ, ÀÇ»ç¼ÒÅë, ÀÏ»ó ¾÷¹« ¼öÇàÀ» ±× ¾î´À ¶§º¸´Ù ½±°Ô ÇÒ ¼ö ÀÖ°Ô ÇØÁÙ °ÍÀÔ´Ï´Ù. ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó BCI°¡ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â °¡´É¼ºÀº °è¼Ó È®´ëµÇ°í ÀÖÀ¸¸ç, Àΰ£ÀÇ ÇູÀ» À§ÇØ ¸¶À½°ú ±â°è°¡ ¿øÈ°ÇÏ°Ô Çù·ÂÇÏ´Â ¹Ì·¡¸¦ ¿¹°íÇϰí ÀÖ½À´Ï´Ù.
±â¼úÀû °úÁ¦
½Å°æ ½ÅÈ£¸¦ Á¤È®ÇÏ°Ô ÇØ¼®Çϱâ À§Çؼ´Â °íµµÀÇ ¾Ë°í¸®Áò°ú Çϵå¿þ¾î°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ ½ÅÈ£ ¼öÁý°ú 󸮴 ¿©ÀüÈ÷ Áß¿äÇÑ Àå¾Ö¹°ÀÔ´Ï´Ù. ¿þ¾î·¯ºí ±â±â°¡ »ç¿ëÀÚÀÇ ÀÏ»ó »ýȰ¿¡ ÀÚ¿¬½º·´°Ô ³ì¾Æµé¾î¾ß Çϱ⠶§¹®¿¡ ¿þ¾î·¯ºíÀÇ È£È¯¼º°ú Æí¾ÈÇÔÀ» º¸ÀåÇÏ´Â °Íµµ Àå¾Ö¹°ÀÔ´Ï´Ù. ¶ÇÇÑ, ½ÅÈ£ ÇØ»óµµ¸¦ ³ôÀÌ°í ³ëÀÌÁî °£¼·À» ÁÙÀÌ´Â °Íµµ ¼º´É Çâ»óÀ» À§ÇÑ Áö¼ÓÀûÀÎ °úÁ¦ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¸¦ ±Øº¹Çϱâ À§Çؼ´Â ´ÙÇÐÁ¦Àû Çù¾÷°ú Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇϸç, ³ú-ÄÄÇ»ÅÍ »óÈ£ÀÛ¿ë ±â¼úÀÇ ÀáÀç·ÂÀ» ÃÖ´ëÇÑ ¹ßÈÖÇÒ ¼ö ÀÖµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù.
±â¼úÀÇ ¹ßÀü
ÃÖ±Ù ½ÃÀåÀÇ ¹ßÀüÀº ȹ±âÀûÀ̸ç, ½ÅÈ£ ó¸® ¾Ë°í¸®ÁòÀÇ ÇöÀúÇÑ ¹ßÀüÀ¸·Î µ¥ÀÌÅÍ Àü¼Û ¼Óµµ¿Í Á¤È®µµ°¡ Çâ»óµÇ¾ú½À´Ï´Ù. ½Å°æ Çǵå¹é ±â¼úÀÌ ´õ¿í Á¤±³ÇØÁ® ³ú Ȱµ¿ÀÇ ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú º¯Á¶°¡ °¡´ÉÇØÁ³½À´Ï´Ù. Çϵå¿þ¾î ºÎǰÀÇ ¼ÒÇüÈ·Î ¿þ¾î·¯ºí ±â±â °³¹ßÀÌ ¿ëÀÌÇØÁ® »ç¿ëÀÚÀÇ Æí¾ÈÇÔ°ú Á¢±Ù¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É ¾Ë°í¸®Áò°úÀÇ ÅëÇÕÀ» ÅëÇØ ³ú ½ÅÈ£ÀÇ ÇØµ¶ÀÌ Å©°Ô Çâ»óµÇ¾î °Ç° °ü¸®¿¡¼ °ÔÀÓ±îÁö ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
Àü¹® Áö½Ä ºÎÁ·
BCI °³¹ß¿¡´Â ½Å°æ°úÇÐ, °øÇÐ, ÄÄÇ»ÅÍ °úÇÐ µî ¿©·¯ ºÐ¾ßÀÇ ÇÐÁ¦Àû Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ºÐ¾ßÀÇ Àü¹® Áö½ÄÀº Á¾Á¾ »çÀÏ·ÎȵǾî ÀÖ¾î °øµ¿ Çõ½ÅÀ» °¡·Î¸·´Â Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ú ½ÅÈ£ÀÇ º¹ÀâÇÑ Æ¯¼ºÀº Àü¹® Áö½ÄÀ» ¿ä±¸ÇÏ°í ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·À» ´õ¿í ¾ÇȽÃ۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ±Øº¹Çϱâ À§Çؼ´Â ÇÐÁ¦ °£ Çù¾÷À» ÃËÁøÇϰí, ±³À° ÇÁ·Î±×·¥À» °ÈÇϸç, Ä¿¹Â´ÏƼ ³» Áö½Ä ±³·ù¸¦ Àå·ÁÇϱâ À§ÇÑ °øµ¿ÀÇ ³ë·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.
COVID-19´Â ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI) ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, µµÀü°ú ±âȸ¸¦ µ¿½Ã¿¡ ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÇÑÆíÀ¸·Î´Â °ø±Þ¸ÁÀÇ È¥¶õ°ú R&D ÅõÀÚ °¨¼Ò·Î ÀÎÇØ ÁøÀüÀÌ µÐȵǾú½À´Ï´Ù. ±×·¯³ª ¿ø°ÝÀÇ·á ¼Ö·ç¼Ç°ú °¡»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿ø°ÝÀÇ·á ¹× ½Å°æ ÀçȰ¿¡ BCIÀÇ Ã¤ÅÃÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. Ãʱâ ÁÂÀý¿¡µµ ºÒ±¸Çϰí, ÆÒµ¥¹ÍÀº ¿ø°ÝÀÇ·á·ÎÀÇ ÆÐ·¯´ÙÀÓ ÀüȯÀ» ÃËÁøÇϰí BCI ½ÃÀåÀÇ Àå±âÀûÀÎ ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.
Àå¾Ö º¹±¸ ºÐ¾ß°¡ ¿¹Ãø ±â°£ Áß °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àå¾Ö ȸº¹ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÷´Ü ½Å°æ ÀÎÅÍÆäÀ̽º¸¦ ÅëÇØ ½Å°æÇÐÀû Àå¾Ö¸¦ °¡Áø »ç¶÷µéÀÇ ÀÒ¾î¹ö¸° ±â´ÉÀ» ȸº¹Çϰųª ´É·ÂÀ» °ÈÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀÎÅÍÆäÀ̽º´Â ³ú ½ÅÈ£¸¦ ÇØ¼®ÇÏ¿© ¿ÜºÎ Àåºñ¸¦ Á¦¾îÇϰí À̵¿, Åë½Å ¹× ÀÏ»ó ¾÷¹«¸¦ Áö¿øÇÏ´Â µ¥ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ßÀ» ÅëÇØ BCI ½ÃÀåÀÇ Æ´»õ ½ÃÀåÀº Á¾ÇÕÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇϰí Àå¾ÖÀÎÀÇ ÀÚ¸³À» ÃËÁøÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ÇコÄÉ¾î ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÇコÄÉ¾î ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ÀÎÅÍÆäÀ̽º´Â ³ú¿Í ¿ÜºÎ ±â±â °£ÀÇ Á÷Á¢ Åë½ÅÀ» ¿ëÀÌÇÏ°Ô ÇÏ¿© ÀÇ·á Áø´Ü, Ä¡·á ¹× ÀçȰÀÇ Çõ½Å °¡´É¼ºÀ» Á¦°øÇϸç, BCI´Â ¸¶ºñ, °£Áú ¹× ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº ½Å°æ Áúȯ¿¡¼ Á¡Á¡ ´õ ¸¹ÀÌ Ã¤Åõǰí ÀÖÀ¸¸ç, Á¤È®ÇÑ ½Å°æ ¸ð´ÏÅ͸µ ¹× °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. BCI´Â ÀÇÁ· Á¦¾î, Á¤½Å°Ç° Áø´Ü, ÀÎÁö Ä¡·áÀÇ °È¿¡ À¯¸ÁÇÕ´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ½Å°æ°úÇÐÀÇ ¹ßÀü°ú ÇコÄɾî, °ÔÀÓ, Ä¿¹Â´ÏÄÉÀÌ¼Ç ºÐ¾ß¿¡¼ÀÇ Àû¿ë È®´ë¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ Áö¿ªÀº Çõ½ÅÀ» ÁÖµµÇÏ´Â ¼±µµÀûÀÎ ±â¾÷µéÀÌ ¸¹Àº ÅõÀÚ¿Í ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÁøÇàÇϰí ÀÖ½À´Ï´Ù. ´º·ÎÅ×Å©³î·¯Áö ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ±â¼ú °³¹ßÀ» µÞ¹ÞħÇϴ źźÇÑ ÀÎÇÁ¶ó¿¡ ÈûÀÔ¾î ÀÌ ½ÃÀåÀÇ ¼ºÀå Àü¸ÁÀº À¯¸ÁÇÑ ¹Ì·¡¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¹ßÀü°ú »ó¿ëȸ¦ À§ÇÑ Áß¿äÇÑ °ÅÁ¡À¸·Î¼ÀÇ ÁöÀ§¸¦ À¯ÁöÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ±â¼ú ¹ßÀü, R&D ÅõÀÚ Áõ°¡, ÇコÄÉ¾î ¾ÖÇø®ÄÉÀ̼Ç, °ÔÀÓ ¹× ¿£ÅÍÅ×ÀÎ¸ÕÆ®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼´Â ´Ù¾çÇÑ ¾ÖÇø®ÄÉÀ̼ÇÀ» À§ÇÑ Çõ½ÅÀûÀÎ BCI ±â¼ú °³¹ß¿¡ ÁÖ·ÂÇÏ´Â ½ºÅ¸Æ®¾÷ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ºÅ¸Æ®¾÷Àº ÅõÀÚÀÚµéÀÇ °ü½ÉÀ» ²ø¸ç ÀÌ Áö¿ªÀÇ Àüü BCI ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Brain Computer Interface Market is accounted for $2.5 billion in 2024 and is expected to reach $8.0 billion by 2030 growing at a CAGR of 21.5% during the forecast period. A Brain-Computer Interface (BCI), also known as a Brain-Machine Interface (BMI), is a system that enables direct communication between the brain and an external device, such as a computer or prosthetic limb, without the need for muscular control. BCIs typically use various methods to interpret brain activity, such as electroencephalography (EEG), invasive neural recordings, functional magnetic resonance imaging (fMRI), or near-infrared spectroscopy (NIRS). These systems can be used for a variety of applications, including controlling assistive technologies for individuals with disabilities, augmenting human capabilities, and studying brain function and cognition.
According to the WHO report, around 82 million people will be affected by dementia by 2030 and this number will reach 152 million by 2050. This shows the potential demand for BCI in the coming years.
Potential for improved quality of life
The market holds immense potential for enhancing quality of life. Through seamless interaction between the brain and external devices, it offers revolutionary possibilities in healthcare, communication, and accessibility. Advancements in technology promise greater autonomy for individuals with disabilities, enabling them to control prosthetic limbs, communicate, and perform daily tasks with unprecedented ease. As research progresses, the potential for improved quality of life through BCIs continue to expand, heralding a future where mind and machine collaborate seamlessly for human well-being.
Technical challenges
Signal acquisition and processing remain key hurdles, as interpreting neural signals with high accuracy requires advanced algorithms and hardware. Ensuring compatibility and comfort in wearable is another obstacle, as devices need to seamlessly integrate into users' daily lives. Additionally, enhancing signal resolution and reducing noise interference are ongoing concerns for improving the performance. Overcoming these challenges demands interdisciplinary collaboration and innovative solutions to unlock the full potential of brain-computer interaction technologies.
Advancements in technology
Recent advancements in the market have been revolutionary, with notable progress in signal processing algorithms, enhancing data transmission speeds and accuracy. Neurofeedback techniques have become more refined, enabling real-time monitoring and modulation of brain activity. Miniaturization of hardware components has facilitated the development of wearable devices, improving user comfort and accessibility. Moreover, integration with artificial intelligence algorithms has led to significant enhancements in decoding brain signals for applications ranging from healthcare to gaming and beyond.
Lack of expertise
Developing BCIs requires a multidisciplinary approach, involving neuroscience, engineering, and computer science. However, the expertise in these fields often remains siloed, hindering collaborative innovation. Additionally, the intricate nature of brain signals demands the specialized knowledge, further exacerbating the scarcity of skilled professionals. Overcoming this challenge necessitates concerted efforts to foster cross-disciplinary collaboration, enhance educational programs, and incentivize knowledge exchange within the community.
The COVID-19 pandemic has influenced the Brain-Computer Interface (BCI) market significantly, prompting both challenges and opportunities. On one hand, supply chain disruptions and decreased investments in R&D slowed down advancements. However, the increased demand for remote healthcare solutions and virtual communication technologies accelerated the adoption of BCIs for telemedicine and neurorehabilitation. Despite initial setbacks, the pandemic fostered a paradigm shift towards remote healthcare, potentially bolstering the long-term growth of the BCI market.
The disabilities restoration segment is expected to be the largest during the forecast period
The disabilities restoration is expected to be the largest during the forecast period. Through advanced neural interfaces, it aims to restore lost functionalities or enhance capabilities for those with neurological impairments. These interfaces interpret brain signals to control external devices, aiding in mobility, communication, and daily tasks. With ongoing research and development, this niche of the BCI market strives to offer inclusive solutions, fostering independence and improving quality of life for people with disabilities.
The healthcare segment is expected to have the highest CAGR during the forecast period
The healthcare segment is expected to have the highest CAGR during the forecast period. These interfaces facilitate direct communication between the brain and external devices, offering transformative potential in medical diagnosis, treatment, and rehabilitation. BCI's are increasingly employed in neurological conditions like paralysis, epilepsy, and neurodegenerative diseases, enabling precise neural monitoring and intervention. They hold promise for enhancing prosthetic control, mental health diagnostics, and cognitive therapy.
North America is projected to hold the largest market share during the forecast period. driven by advancements in neuroscience and increasing applications across healthcare, gaming, and communication sectors. With prominent players leading innovation, the region witnesses significant investment and research initiatives. The market's projected growth reflects a promising future, fueled by rising demand for neurotechnology solutions and the region's robust infrastructure supporting technological development. North America stands poised to maintain its position as a key hub for advancements and commercialization efforts.
Asia Pacific is projected to hold the highest CAGR over the forecast period driven by technological advancements, increasing investment in research and development, and a growing demand for healthcare applications, gaming, and entertainment. Furthermore, there was a growing trend of startups emerging in the Asia Pacific region, focused on developing innovative BCI technologies for various applications. These startups were attracting attention from investors and contributing to the overall growth of the BCI market in the region.
Key players in the market
Some of the key players in Brain Computer Interface market include Natus Medical Inc., NeuroSky, Advanced Brain Monitoring Inc., Cadwell Industries Inc., Medtronic PLC, Emotive Incorporation, NextMind, Brain Products GmbH, Nihon Kohden Corporation, NIRx Medical Technologies, Ripple Neuro, Integra LifeSciences Corporation, Mind Technologies Inc., Covidien, PLC and Compumedics, Ltd.
In April 2024, Medtronic plc announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO(TM), the latest generation software for the GI Genius(TM) intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care.
In January 2024, Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval of its Percept(TM) RC Deep Brain Stimulation (DBS) system. The rechargeable neurostimulator is the latest innovation in the Medtronic Percept(TM) family, which includes the Percept(TM) PC neurostimulator, BrainSense(TM) technology+, and SenSight(TM) directional leads.